Bacteriophage P4 DNA replication depends upon the phage-encoded ␣ protein, which has DNA helicase and DNA primase activity and can specifically bind to the replication origin (ori) and to the cis replicating region (crr). The P4 Cnr protein functions as a negative regulator of P4 replication, and P4 does not replicate in cells that overexpress cnr. We searched for P4 mutants that suppressed this phenotype (Cnr resistant [␣cr]). Eight independent mutants that grew in the presence of high levels of Cnr were obtained. None of these can establish the plasmid state. Each of these mutations lies in the DNA binding domain of gp␣ that occupies the C terminus of the protein. Five different sequence changes were found: T675M, G732V (three times), G732W (twice), L733V, and L737V. A TrxA-Cnr fusion protein does not bind DNA by itself but stimulates the ori and crr binding abilities of ␣ protein in vitro. The ␣cr mutant proteins were still able to bind specifically to ori or crr, but specific DNA binding was less stimulated by the TrxA-Cnr protein. We present evidence that Cnr protein interacts with the gp␣ domain that binds specifically to DNA and that gp␣cr mutations impair this interaction. We hypothesize that gp␣-Cnr interaction is essential for the control of P4 DNA replication.
Satellite phage P4 can replicate bidirectionally via the -mode under the control of its own initiator protein (6, 15) . This protein, called gp␣ (777 amino acids), has DNA binding, helicase, and primase activity (31) . The targets for DNA binding are the origin (ori) and the cis-replication region (crr), which are both required for replication. The latter region lies 4.5 kb from ori and contains the same repeating octamer (type I repeat), TGTTCACC, that is found in ori (8) . Another repeated sequence of ori is YCACYTAAAG (type II repeats). gp␣ recognizes and binds exclusively to type I repeats, not to type II iterons (31) . Looping between ori and crr was detected in vitro in the presence of gp␣ in supercoiled or linear P4 DNA (29) . The DNA binding activity of ␣ protein lies near its C terminus (30) , while the primase activity is near the N terminus (26) . Both domains containing these activities can function independently from each other: the N-terminal truncation containing the primase domain complements a P4 primase-null phage and retains primase activity in vitro (26) . The C-terminal 150 amino acids of gp␣ have specific DNA binding activity in vitro. The helicase domain, probably spanning the middle and the C-terminal third of gp␣, requires the integrity of a large fraction of the protein (28) .
P4 requires the late gene products of a helper phage from the P2 family to produce progeny (18) . In the absence of a helper, it can replicate as a plasmid (5, 9, 21) . The copy number of P4 is negatively regulated by the P4 cnr gene, which lies upstream of the ␣ gene in the same transcription unit (27) . In the absence of Cnr, P4 overreplicates, and this leads to cell killing. As a consequence, phage production in the lytic cycle is decreased, and propagation of P4 in the plasmid state is impaired. Overexpression of cnr from a plasmid inhibits P4 DNA replication (27) . The target of action of the Cnr protein was not previously known. To define this target, we have isolated P4 ␣ mutants resistant to the inhibitory action of Cnr. We conclude that Cnr protein interacts with gp␣ to limit DNA replication by a novel mechanism.
MATERIALS AND METHODS
Bacterial strains, plasmids, phages, and media. The Escherichia coli strains and P4 phages used are listed in Table 1 . P4 coordinates are from the updated DNA sequence (GenBank accession no. X51522 [10, 32] ). High-titer stocks of P4 were prepared on P2-lysogenic host strains as described before (14) . The plasmids used are listed in Table 2 . The media used for P4 growth are described by Kahn et al. (14) . Cells harboring plasmids were grown in YT medium (20) buffered with 25 mM 3-(N-morpholino)propanesulfonic acid (sodium salt; pH 8.0) and supplemented with 0.1% glucose and 25 g of thiamine-HCl per ml. When appropriate, 100 g of ampicillin (sodium salt) per ml or 10 g of chloramphenicol per ml was added. GI724(pTZ106) was grown in IMC broth (16) with 100 g of ampicillin (sodium salt) per ml.
Isolation of P4 phages resistant to Cnr. The P4 mutants resistant to Cnr were isolated starting from different genetic backgrounds: P4, P4 vir1, P4 del51, P4 del51 vir1, and P4 vir1 ␦R73. This variety was used to enlarge the probability of obtaining a diversity of mutants. About 10 7 phage were plated on C-2422 (pST106), giving rise to two to five plaques in each experiment. The efficiency of plating of the mutant phages on C-2422 and C-2422(pST106) was measured. After the mutations were mapped, P4 vir1 derivatives carrying the different mutations were constructed by in vitro recombination. The mutant phages are listed in Table 1 .
Mapping and sequencing of the cr mutations. The DNA fragment exchange procedure was described by Ziegelin et al. (30) . DNA fragments exchanged to map the mutations and to construct P4 vir1 derivatives were sequenced.
DNA techniques. Standard techniques for plasmid DNA isolation and molecular cloning were used (22) . To amplify cnr and to introduce a NdeI recognition site as part of the ATG start codon, the following oligodeoxynucleotides served as primers (P4 sequences underlined): AACATATGAAAACACCCTTACCGC CCG-TCTTAC (5Ј end of cnr) and TTGTCGACGTTGTTCTCCTTCAGTGC AGTACCGG (3Ј end of cnr). For PCR, we supplied pMS4 (Table 2) as a template and deep vent DNA polymerase, which has proofreading activity. Following PCR, the reaction mixture was phenol extracted and the DNA was ethanol precipitated. After cleavage with NdeI, the amplified fragments were separated from primers and template DNA by agarose gel electrophoresis. DNA was sequenced by the dideoxy chain termination method (23) with T7 DNA polymerase (Pharmacia). The amplified cnr gene was sequenced and found to be identical to the published nucleotide sequence (10) . ␣cr-overexpressing plasmids were constructed by exchanging the P4 BamHI-AscI fragment containing the cr mutation into pMS4⌬1 to result in pMS4⌬0.5cr. pGZ4⌬1cr was generated by insertion of the EcoRI-EcoRV fragment of pMS4⌬0.5cr into pGZ119EH.
Partial purification of gp␣cr proteins. The procedure described by Ziegelin et al. (31) was slightly modified. The cells were lysed in the absence of high NaCl concentrations to keep ␣ protein precipitated. Following centrifugation, the pellet containing ␣ protein was washed in lysis buffer without salt to remove soluble cellular polypeptides. After solubilization of gp␣cr with buffer containing 1 M NaCl and centrifugation, the dialyzed supernatant was fractionated on heparin-Sepharose CL-6B as described previously (31) . The protein was approximately 90% pure.
Construction of plasmids overexpressing trxA-cnr fusion genes. The cnr gene of pST106 (NdeI-BamHI fragment) was fused to the trxA gene of pTRXFUS (16) to give pTZ106. pTRXFUS contains trxA under the transcriptional control of p L and the translational control of the cII ribosome binding site. E. coli GI724 delivers chromosomally encoded repressor controlled by p trp . Hence, tryptophan-free medium is required to maintain the repression of the trx-fusion. To adapt the production of TrxA-Cnr to our convenient p tac /lacI-regulated system in a recA background (30) , the trxA-cnr fusion including the cII ribosome binding site (NsiI-BamHI fragment) was inserted into pMS119HE prepared with PstI and BamHI to result in pTZ1106. To facilitate the purification of TrxA-Cnr, we inserted a (His) 6 tag into the active-site loop of the thioredoxin portion of trxA-cnr by using the unique RsrII site of pTZ1106 to give pTZ1106His.
Purification of TrxA-(His) 6 -Cnr protein (Cnr-th). A 500-ml culture of SCS1(pTZ1106His) was grown at 37°C with shaking. At an absorbance at 600 nm (A 600 ) of 0.5, isopropyl-␤-D-thiogalactopyranoside (IPTG) was added to 1 mM. Shaking was continued for 5 h. Cells were centrifuged at 4,000 ϫ g for 10 min, resuspended in 1 mM spermidine Tris HCl-200 mM NaCl-2 mM EDTA (pH 7.5) (1 g of wet cells in 5 ml), and frozen in liquid nitrogen. All the following steps were performed at 0 to 4°C. Frozen cells were thawed (3 g in 15 ml) and adjusted to 40 mM Tris-HCl (pH 7.6)-4% sucrose-0.13% Brij 58-1 M NaCl-2.5 mM dithiothreitol (DTT)-0.3 mg of lysozyme per ml. Following incubation for 1 h, the highly viscous lysate was centrifuged at 100,000 ϫ g for 60 min. To remove soluble cellular proteins, the pellet was washed twice with 1 M NaCl in buffer A (20 mM Tris-HCl [pH 7.6], 2.5 mM DTT, 1 mM EDTA) by rigid homogenization. Then the pellet was resuspended twice in 6 M urea-1 M NaCl in buffer A to dissolve Cnr-th protein. The supernatants of both urea steps were combined (fraction I; 43 ml), and the proteins were precipitated with ammonium sulfate at 60% saturation. The pellet was solubilized in buffer B (6 M urea, 50 mM NaH 2 PO 4 [pH 8 .0], 300 mM NaCl) containing 20 mM imidazole-HCl (pH 8.0) and dialyzed against buffer B-20 mM imidazole-HCl (pH 8.0) (fraction II; 42 ml). A 21-ml volume of fraction II was applied at 5 ml/h to a Ni 2ϩ -nitrilotriacetic acid column (0.9 by 7.5 cm) equilibrated with buffer B-20 mM imidazole-HCl (pH 8.0). The column was washed with 20 ml of buffer B-20 mM imidazole-HCl (pH 8.0). The proteins were eluted with 250 mM imidazole-HCl (pH 8.0) in buffer B. Peak fractions containing Cnr-th were pooled (13 ml) and dialyzed four times against 20 ml of buffer C (20 mM Tris-HCl [pH 7.6], 50 mM NaCl, 1 mM DTT, 1 mM EDTA) to renature the protein and then twice against a 10-fold volume of buffer C to get rid of residual urea. The fraction was concentrated by dialysis against 20% polyethylene glycol 20000, dialyzed against 50% glycerol in buffer C (fraction III; 1.4 ml), and stored at Ϫ20°C.
Fragment retention assay. DNA fragments containing ori or crr were incubated with gp␣ and Cnr protein for 30 min at 37°C in a total volume of 20 l of buffer containing 20 mM Tris-HCl (pH 7.6), 100 mM NaCl, and 10 g of bovine serum albumin per ml and electrophoresed on nondenaturing 3.5% polyacrylamide gels as described before (31) . The DNA bands were stained with ethidium bromide, visualized and documented with a FluorImager 575 (Molecular Dynamics), and analyzed with ImageQuant software version 3.3 (Molecular Dynamics). Since both ori and crr fragments were complexed specifically by gp␣ forming large aggregates that do not enter polyacrylamide or agarose gels (31), the decreasing intensity of the uncomplexed ori or crr band was measured. The sources of P4 ori or P4 crr fragments were the double-stranded M13mp18 derivatives mMSP4ori or mMSP4crr containing the 361-bp ori or the 335-bp crr fragment inserted into the HincII site of the multiple-cloning site (Table 2) . Digestion with EcoRI, HindIII, and BglII yielded ori-or crr-containing fragments of 412 or 386 bp, respectively and additional fragments of 653 and 6,597 bp. The 653-and 6,597-bp fragments served as competitor DNA.
RESULTS
Isolation of P4 mutants resistant to the action of Cnr. Expression of cnr from a plasmid inhibits P4 lytic growth (27) . To define the target of action of the Cnr protein, we have sought . The phages of these plaques plated on C-2422(pST106) with an efficiency of 1. We isolated eight independent P4 mutants of this type. These Cnr-resistant mutants were called cr.
The cr mutations map in the 3 half of the ␣ gene. The eight mutations were mapped by fragment exchange as described in Materials and Methods. All were located within P4 coordinates 4261 to 5653. This part of the P4 genome contains the 3Ј end of the ␣ gene and the cis replication region (crr). To demonstrate that the mutations did not lie in crr, we exchanged the EcoRV fragment (positions 3970 to 4596) containing crr from the mutants into P4 vir1 and found the phage to be inhibited by Cnr protein encoded by pST106. Since we used genetically different P4 phages to search for Cnr resistant mutants but obtained mutations only in the 3Ј end of the ␣ gene, we surmise that Cnr acts only at the C-terminal half of gp␣.
cr mutations are clustered within the DNA binding domain of gp␣. The DraIII-BamHI segments (positions 5653 to 4261) derived from the eight mutants were inserted into pGZ119EH and sequenced to determine the exact position of the mutation. All mutants contained a single base exchange leading to a single amino acid exchange. We found that the first and second bases of codons were affected. The positions, the exchanges, and the number of respective mutants are summarized in Table 3 . Except for T675M, all the mutations were clustered between gp␣ amino acids 732 and 737. Most of the exchanges increase the local hydrophobicity of gp␣. This indicates that these positions may be important in the interaction with Cnr either by direct protein-protein contact or by stabilization of a certain conformation required for gp␣-Cnr interaction. However, it could not be ruled out that Cnr might control P4 replication indirectly, for instance by activating a cellular protein that interacts with gp␣.
The ␣cr mutations impair P4 propagation in the plasmid state. The Cnr protein is essential for the control of P4 copy number when P4 propagates as a plasmid. A phage carrying a deletion of the cnr gene overreplicates and causes death of the host cell (27) . We tested whether the P4 ␣cr mutants were able to establish the plasmid state after infection of E. coli. Infection of strain C-1a with each of the P4 vir1 ␣cr mutants caused severe cell killing, and no plasmid P4 carriers could be found among the survivors (Table 4) . Thus, all the ␣cr mutations impair P4 plasmid propagation, suggesting that the mutations compromise the negative control of Cnr on DNA replication.
Overexpression of Cnr proteins. cnr could not be expressed efficiently under the control of the native cnr ribosome binding site in the lacI regulated expression plasmid pMS4 (data not shown). Therefore, we used pST106 in which an amplified P4 DNA fragment encoding Cnr was fused to the efficient ribosome binding site of T7 gene 10 retaining the original cnr nucleotide sequence. This plasmid was suitable for producing Cnr in large quantities (Fig. 1, lane b) . A polyclonal Cnr-thspecific antiserum was prepared from the purified Cnr-th protein [(TrxA-(His) 6 -Cnr); see below]. In both SCS1(pMS4) and SCS1(pST106) cell extracts, the cross-reacting product corresponded in size to the overproduced Cnr protein (data not shown), and this product was not detectable in cells harboring the vector plasmid. This suggests that the protein overproduced from SCS1(pST106) containing a cnr gene genetically manipulated at the 5Ј end is identical to the molecule encoded by pMS4. The overproduced Cnr protein was highly insoluble in nondenaturing buffers. Following solubilization in 6 M urea, the protein was precipitated during dialysis against physiolog-FIG. 1. Overproduction of Cnr proteins. Cells containing various cnr-overexpressing plasmids were grown at 37°C [GI724(pTZ106) at 30°C] to an A 600 of 0.5. IPTG was added to 1 mM. For GI724(pTZ106), tryptophan was added to 100 g/ml. Shaking was continued for 4 h. Cell extracts from cells with an A 600 of 0.08 were electrophoresed on denaturing 17.5% polyacrylamide gels containing 0.1% sodium dodecyl sulfate. After electrophoresis, proteins were stained with 0.25% Coomassie brilliant blue R-250. Cnr-th denotes the TrxA-(His) 6 -Cnr fusion protein encoded by pTZ1106His. Lanes: ϩ, extracts of induced cells, Ϫ, extracts of noninduced cells; M, marker proteins. The cnr-overexpressing plasmids are indicated above the lanes. The marker proteins were bovine serum albumin (68 kDa), ovalbumin (43.6 kDa), chymotrypsinogen (21.5 kDa), lysozyme (14.3 kDa), and aprotinin (6.8 kDa). ical buffers. Since thioredoxin A fusions circumvent inclusion body formation of certain proteins in the E. coli cytoplasm (16), we fused the N terminus of Cnr to thioredoxin A by using different vectors to give pTZ106 and pTZ1106 (see Materials and Methods). Both constructs encode the TrxA-Cnr fusion. Following induction, GI724(pTZ106) and SCS1(pTZ1106) overproduced a protein with the expected molecular mass (lanes c and d). The fusion protein of either strain remained soluble under physiological conditions. Although the hexahistidine-tagged TrxA-(His) 6 -Cnr derivative (Cnr-th) encoded by pTZ1106His was produced as efficiently as TrxA-Cnr (lane e), the His-tagged fusion polypeptide was insoluble. However, after solubilization in 6 M urea and renaturation by dialysis against physiological buffers, Cnr-th remained in solution.
N-terminal modifications of Cnr reduce activity. To decide whether these fusions are suitable for in vitro studies, we wished to test whether the proteins retained Cnr activity in vivo. Thus, we infected C-2422 and three of its plasmid-carrying derivatives with P4 vir1 and measured the burst sizes. Table  5 shows that wild-type Cnr reduced the burst of P4 progeny by 47-fold whereas TrxA-Cnr reduced the P4 burst by only 8-fold and Cnr-th reduced the P4 burst by only 4-fold. Thus, the fusion proteins are less active than wild-type Cnr, but they still have measurable activities. This conclusion was confirmed by the efficiencies of plating of P4 vir1 on the different strains summarized in Table 5 .
Purification of Cnr-th. The (His) 6 tag of Cnr-th allows isolation of the protein by a single column purification step, since it binds selectively to an Ni 2ϩ -chelating matrix from which it was easily eluted. The Cnr-th protein obtained by the procedure described in Materials and Methods was approximately 95% pure.
Cnr-th stimulates the binding of gp␣ to ori or crr. In vivo, cnr overexpression inhibits P4 DNA replication. This inhibition is suppressed by the concurrent overexpression of ␣ (27) . Therefore, we assumed that Cnr either binds to the origin to prevent access of gp␣ or interacts with gp␣ to alter one or several of its replication activities. Cnr-th did not bind specifically or nonspecifically by itself to double-stranded or singlestranded DNA (data not shown). To analyze the effects of Cnr on gp␣-DNA interaction, ori or crr fragments in combination with competitor DNA were incubated with gp␣ at a subsaturating concentration and with increasing amounts of Cnr-th. The amount of gp␣ used in the assay was such that a portion of the ori fragment was bound. The amount of unbound fragment in the absence of Cnr-th was set 100%. Protein-DNA complex formation was analyzed on nondenaturing polyacrylamide gels (see Materials and Methods). Increasing amounts of Cnr-th decreased the fraction of unbound ori or crr DNA fragments ( Fig. 2A and B) . At a 25-fold molar excess of Cnr-th over gp␣, the fraction of unbound ori or crr was reduced by approximately 10-fold without binding to competitor DNA ( Fig. 2A and B) . At lower ratios, this stimulation of binding was weaker. Cnr-th enhanced the binding of ␣ protein to ori and cnr equally well, indicating interactions between gp␣ and Cnr-th. The excess of Cnr-th required may be due to weak protein-protein interactions, to steric hindrance of the TrxA portion resulting in a less active Cnr protein, or to partially active Cnr-th protein that was not completely renatured.
The stimulatory effect of Cnr-th on ␣cr proteins is reduced. Since Cnr-th enhances the specific DNA binding capability of gp␣, the Cnr-resistant phenotype may be due to gp␣ molecules that either interact more weakly with ori/crr or are not stimulated by Cnr-th to bind ori/crr. To test these hypotheses, two different ␣cr proteins were partially purified by chromatography on heparin-Sepharose (see Materials and Methods) and tested for complex formation with ori or crr in the presence and absence of Cnr-th. We chose gp␣crT675M and gp␣crG732W to analyze the effect of mutations in separated regions of the protein. Specific binding of both mutant ␣ proteins to ori or crr was not significantly different from that of the wild-type protein. However, in the presence of Cnr-th, both gp␣cr were less stimulated in complexing ori than was the wild type protein (Fig. 2C) . At a 25-fold molar excess of Cnr-th over the ␣cr molecules, binding was only weakly enhanced. No significant differences between gp␣crT675M and gp␣crG732W could be observed. Similar observations were made with crr instead of ori (data not shown). These results demonstrate that amino acids T675 and G732 were not essential for the DNA binding specificity but are involved in interacting with Cnr-th or in stabilizing a structure important for gp␣-Cnr interactions.
DISCUSSION
The P4 Cnr protein is a small molecule of 106 amino acid residues (11,802 Da) with four cysteines and a calculated pI of 7.4. The overall character of Cnr is hydrophilic according to the prediction method of Engelman et al. (7) . From the amino acid composition or its sequence, it is not clear why this protein is so insoluble. Derivatization of the N terminus of Cnr by thioredoxin only partially moderated the problem of solubility, and this increase in solubility was achieved at the cost of losing in vivo activity. The lower activity of TrxA-Cnr and TrxA-(His) 6 -Cnr (Cnr-th) compared to wild-type Cnr might indicate the importance of a freely available N terminus for efficient Cnr function. Thus, reduction of activity might be due to steric hindrance by the TrxA moiety in the interaction between Cnr and gp␣. On the other hand, the Cnr fusion proteins might be adequate to control P4 replication. In our experiments, Cnr proteins were delivered in trans by plasmids. The slight leakiness of the p tac /lacI system causes background level expression of the Cnr polypeptides. Since the 5Ј end of each cnr gene contributes to the ribosome binding site and therefore to the efficiency of translation initiation, the cellular concentration of each Cnr protein would be different. This could also contribute to the reduced in vivo activity of Trx-Cnr and Cnr-th.
The amino acid sequence does not offer any hint to the possible function of the protein as a negative regulator of the copy number in the P4 plasmid state (27) . To unravel the mechanism of Cnr action, we have followed a combined in vivo and in vitro approach.
P4 mutants able to plate on a cnr overexpressing strain, which is not permissive for wild-type P4, have mutations that map in the ␣ gene, specifying the initiator protein of P4 DNA replication. The mutations are clustered in a 60-amino-acid subdomain of the C-terminal 150-amino-acid-residue domain of gp␣ that directs specific origin recognition and binding. The ␣cr mutations do not alter P4 lytic growth but impair propa- a E. coli C-2422 carrying the indicated plasmids was grown at 37°C in LuriaBertani broth without IPTG inducer. The cells were infected with P4 vir1, and the burst size was measured after 2 h as described by Ziegelin et al. (30) . Cnr-th denotes the TrxA-(His) 6 -Cnr fusion polypeptide. gation in the plasmid state. This suggests that the DNA replication ability of the mutated gp␣ is not affected but, rather, that the proteins are insensitive to the negative control of Cnr, which is essential in the plasmid state.
The sites of mutation in gp␣ indicated that Cnr might interact with gp␣ and influence the DNA binding affinity. Indeed, the presence of Cnr-th in the DNA binding assay increased the affinity of gp␣ to ori or crr. In contrast, Cnr-th has a much smaller effect on the specific DNA binding affinity of the ␣cr mutant proteins, probably due to their amino acid exchanges. These mutations suppress the phenotype of P4 growth inhibition at high cellular Cnr concentrations. Since Cnr-th does not bind to DNA by itself, we concluded that Cnr-th interacts with ␣ protein directly either by complex formation or by alteration of the conformation of the DNA binding domain. This raises the question whether Cnr is present in the complex of gp␣ and DNA. We also concluded that the interaction of Cnr-th and gp␣ must be rather weak, because Cnr-th is needed in a 25-fold excess over gp␣ to detect the Cnr-induced stimulation in DNA binding. Cnr-th might have a reduced activity due to conformational changes triggered by the Trx moiety. Taking into account the weaker inhibitory effect of Cnr-th on phage propagation compared to that of Cnr, it could be expected that Cnr itself interacts more strongly with gp␣ than does Cnr-th. Since increased cellular concentrations of Cnr inhibit P4 DNA replication, the complexes formed between ␣-Cnr and DNA are probably unable to allow for initiation of replication.
The initiation of DNA replication is usually regulated by temporarily inactivating origins. Examples are the antisense RNA model and the iteron model. The copy number of E. coli plasmids of the ColE1 family is regulated at the level of the formation of an RNA molecule that serves as a primer for DNA polymerase I. Negative regulation is obtained by the interaction between the precursor of the primer and RNA I, a plasmid-encoded small antisense RNA. The RNA-RNA interaction between the two regulatory molecules is modulated by the Rop protein (4). Currently, there is no indication that the control of P4 DNA replication initiation involves a regulatory RNA species. Certain plasmids, such as P1 and RK2/RP4, are thought to control their replication by dimerization (12) . A replicator protein binds to several copies, or iterons, of a specific nucleotide sequence. When the copy number is too high, the multiple molecules of replicator protein bound to the iterons cause the DNA-protein complexes to dimerize and be- come inactive. The formation of gp␣-P4 DNA aggregates might be interpreted as an equivalent to those dimerized inactive complexes. However, P4 seems to use a novel mechanism to control replication: interaction of gp␣ with Cnr increases the binding affinity for ori, yielding protein-DNA complexes inactive in initiation of replication.
The ␣ protein has three distinct replication functions: ori/crr recognition and binding, DNA helicase, and DNA primase. Of these activities, only the DNA binding ability is influenced in the presence of Cnr-th. Under the conditions used, Cnr-th apparently does not affect ATPase or reduce or increase the helicase or primase activity (data not shown). These findings suggest that blocking the initiation of DNA replication occurs already in the initial step of replication, the formation of an initiation complex between the origin and the initiator protein.
Support for this conclusion comes from the location of mutations that render P4 DNA replication insensitive to increased Cnr concentrations. The eight single amino acid exchanges localize to the DNA binding domain at the C terminus of ␣, and seven of them are clustered within a stretch of six residues, 732 to 737. These residues might not be involved in DNA binding directly, but Cnr-gp␣ interaction could change the conformation of gp␣. In addition, the mutated residues do not appear to be involved in DNA binding, because the DNA binding ability of the ␣cr proteins remained unchanged compared with wild-type gp␣.
Since Cnr-th neither stimulates nor inhibits the primase or helicase activity of gp␣, some other event in initiation should be affected. Hence, we assume that replication initiation is inhibited at an early stage. Taking into account the stimulatory effect of Cnr-th on the specific DNA binding ability of gp␣, we speculate that Cnr arrests the initiator protein at the origin to prevent the formation of an initiation complex that is ready for local unwinding.
